Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2024 | Story André Damons | Photo André Damons
Dr Innocensia Mangoato
Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. Here she is with her supervisor and mentor Prof Motlalepula Matsabisa, Director of the University of the Free State (UFS) Department of Pharmacology.

A lecturer and researcher from the University of the Free State (UFS) Department of Pharmacology hopes her research into the use of cannabis in reversing anticancer drug resistance is a step forward into treating various cancers especially in Southern Africa.

Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with the degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. She started her career as a research scientist in the area of African traditional medicines in 2018 and her research received both national and international recognition.

“It’s an amazing (feeling to graduate today). My PhD journey was smooth and beautiful and with mentorship of Prof (Motlalepula) Matsabisa, who groomed me well, I did not shed a tear,” said Dr Mangoato. Dr Gudrun S Ulrich-Merzenich from the University of Bonn in Germany, was her co-supervisor with Prof Matsabisa.

According to the graduation programme, Dr Mangoato, Lecturer and Researcher in the UFS Department of Pharmacology, with her thesis titled Investigating the anticancer and possible resistant reversal effects of cannabis sativa l. extracts in cervical cancer cell lines and modulation of ABC transporters comprehensively explored the therapeutic potential of Cannabis sativa L. in overcoming drug resistance in cervical cancer using in vitro and network pharmacology approaches.

A step forward for treating various cancers

The research looked at the chemical fingerprints and pharmacological targets of C. sativa L. extracts, highlighting its antiproliferative properties against normal non-cancerous cells, cervical cancer cells and the cisplatin-resistant cervical cancer cells. Through PCR analysis, distinct gene expression profiles were identified, revealing the potential effects of combination treatments to counteract cisplatin resistance by downregulating genes associated with drug transporters and crucial signalling pathways. This work provides valuable insights into innovative therapeutic strategies for improving cervical cancer treatment, highlighting new avenues for overcoming resistance and enhancing treatment efficacy though the possible use of plant extracts.

“I hope my research takes a step forward in treating various cancers – especially gynaecology cancers in the Southern Hemisphere in Africa. Hopefully the research can later transcend into clinical trials and hopefully influence more policymakers. We also hope to further develop cannabis to be used as an adjuvant therapy for those drugs that are failing to treat cancer,” says Dr Mangoato, who was the recipient of the Women in Science Master’s Student in 2018.

Her graduation was also a proud moment for Prof Matsabisa, an expert in traditional African medicine, who was like a father to her during her studies. “Prof identified me from my honours degree and walked this journey with me. He has been a great mentor, a father and an amazing supervisor.”

Dr Mangoato says she will for now focus on research only and helping and monitoring upcoming researchers, especially female researchers as there is a scarcity of them her field. 

News Archive

Head of SA Witness Protection Programme pays UFS a visit
2010-05-04

 
Receiving the Head of the South African Witness Protection Programme are, in front: Prof. Hennie Oosthuizen, Head of the Department of Criminal and Medical Law at the UFS; back: Adv. Beatri Kruger from the UFS Unit for Children’s Rights, Ms Lani Opperman, Member of the Free State Human Trafficking Forum (FHF), Adv. John Welch, Head of the Witness Protection Programme in South Africa; and Lene van Zyl, a LLM student at the UFS who is doing her thesis on human trafficking in body parts.
Photo: Leonie Bolleurs


Recently Adv. Beatri Kruger from the Unit for Children’s Rights in the Faculty of Law at the University of the Free State (UFS) invited Adv. John Welch, Head of the Witness Protection Programme in South Africa, to address the Free State Human Trafficking Forum (FHF) on the safe-keeping of victims who are witnesses against human traffickers.

Human trafficking is prevalent in the Free State, especially in Bloemfontein. The Unit for Children’s Rights is one of the founding members of the FHF that was established to take action against and fight the disturbing reality of human trafficking more efficiently.

According to Adv. Kruger the FHF identified the problem of trafficked witnesses being threatened by human trafficker syndicates.

Adv. Welch made some suggestions with regard to the safe-keeping of trafficked victims. He also, with some of the forum members, paid a visit to the areas in Bloemfontein where human trafficking is prevalent as well as to the local shelter for trafficked victims.

Adv. Welch undertook to join forces with the FHF in assisting trafficked victims and the local Witness Protection Programme Office is now a member of the forum.

Since December 2009 members of the FHF managed to disrupt the work of the human trafficking syndicates. “The traffickers have not stopped this inhumane practice but there are indications that they have moved to other buildings in the inner city and even to houses in the suburbs. It was reported to the forum that approximately 27 males suspected of being involved in human trafficking had been arrested, and since they are illegal in the country, they were deported to their countries of origin,” said Adv. Kruger.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept